.png){kind=logo}
Avalanche could reach $50 soon.
NEAR Protocol experiences resurgence as it launches its AI roadmap.
Milei Moneda offers better profit margins.
Avalanche (AVAX) welcomes a RWA tokenization platform to its network. NEAR Protocol (NEAR) commits to further improvement of its AI capabilities. Meanwhile, Milei Moneda ($MEDA) draws investors' attention with better profit margins.
How wide are these margins? And do they make $MEDA the best crypto to invest in ahead of Avalanche and Near Protocol? Let's find out!
On April 16, 2024, CoinDesk revealed that Homium, a real-estate equity mortgage lender and securitization platform, had started offering home equity loans on Avalanche.
This move is in line with Avalanche's efforts to participate in the fast-growing real-world asset (RWA) tokenization sub-niche. The coming of Homium could make the network one of the leaders in the RWA sub-niche.
Homium loans are currently only available in the US state of Colorado. Homeowners contribute a percentage of their property's price appreciation, while investors finance the loan with a tokenized asset that tracks the price appreciation of a pool of shared appreciation home loans issued on Homium.
Since the loans went live, AVAX has gained 11.1%, rising from $35.16 to $39.05. Analysts say the interest generated by this new development might be responsible for AVAX's pump.
They add that AVAX could further surge to $50 if investor interest is sustained.
On April 10, it was reported that NEAR Protocol CEO Illia Polosukhin presented a deck that outlines the project's AI roadmap. One important part of the plan is to hire AI engineers to build a user-owned AI.
NEAR Protocol's AI platform, near.ai, will be launched externally in May. The project believes it has the responsibility to make AI open source because of its decentralized and not-for-profit nature.
This roadmap figures into the industry-wide effort to integrate AI and crypto, with NEAR Protocol looking to play a leading role.
Despite the interest in NEAR's latest project, market conditions deteriorated after being affected by political tensions in the Middle East. NEAR fell from $7.21 to $4.92 in the ensuing confusion.
However, with tensions cooled, NEAR rebounded by 41% to around the $6.94 level. Analysts predict that NEAR can reach $11.80 during this recovery period. The upcoming developments and the expected price recovery make NEAR one of the altcoins to watch.
Milei Moneda is a unique meme coin that offers investors a comprehensive blockchain experience. The project's ecosystem includes politics, humor, community, NFTs, and much more.
In addition, investors are guaranteed financial gains when they invest in Milei Moneda's presale. The presale is currently in Stage 2, and $MEDA is sold for $0.0125. Investors who buy $MEDA now will earn a 60% profit when the project launches at $0.020.
Interestingly, Stage 1 investors have already gained 25% of their initial investment. They will eventually gain 100% at launch.
The certainty and margin of Milei Moneda's profits make it the best cryptocurrency to buy now. However, the project offers much more. 5% of $MEDA's supply will be burned to create scarcity and more opportunities for a price increase.
Also, investors become part of the Milei Moneda community. They can attend virtual events, participate in Q&A sessions, and win giveaways. Investors also get access to exclusive NFT collections, earn NFT staking rewards, get voting rights, and enjoy discounts.
Finally, Milei Moneda protects investors' funds through locked liquidity, smart contract audits, and zero team allocations. These additional benefits make $MEDA a more attractive prospect than AVAX and NEAR.
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.
